Moberg Pharma AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	13.54	9.81	-	0.21	-
Revenue Growth (YoY)	37.99%	-	-	-	-
Cost of Revenue	5.86	3.5	-	-	-
Gross Profit	7.68	6.32	-	0.21	-
Selling, General & Admin	32.14	28.97	24.86	21.07	18.51
Research & Development	3.54	302.23	3.66	1.18	3.45
Other Operating Expenses	-	-	-0.61	-1.52	-2.23
Operating Expenses	35.68	331.2	27.91	20.72	19.73
Operating Income	-28	-324.89	-27.91	-20.52	-19.73
Interest Expense	-0.18	-0.23	-0.26	-0.07	-0.13
Interest & Investment Income	3.48	4.58	2.3	0.79	-
Currency Exchange Gain (Loss)	0.68	0.06	0.45	0.29	-
Other Non Operating Income (Expenses)	-	-	-	-	-0.11
EBT Excluding Unusual Items	-24.02	-320.47	-25.42	-19.51	-19.97
Pretax Income	-24.02	-320.47	-25.42	-19.51	-19.97
Income Tax Expense	3.22	-65.36	-4.33	-3.8	-3.75
Earnings From Continuing Operations	-27.24	-255.11	-21.09	-15.71	-16.22
Earnings From Discontinued Operations	-	-	-	-	23.59
Net Income to Company	-27.24	-255.11	-21.09	-15.71	7.37
Minority Interest in Earnings	-	-	-	-	0.13
Net Income	-27.24	-255.11	-21.09	-15.71	7.49
Net Income to Common	-27.24	-255.11	-21.09	-15.71	7.49
Net Income Growth	-	-	-	-	27.73%
Shares Outstanding (Basic)	47	38	16	8	4
Shares Outstanding (Diluted)	47	38	16	8	4
Shares Change (YoY)	23.78%	138.46%	109.19%	76.28%	127.45%
EPS (Basic)	-0.58	-6.74	-1.33	-2.07	1.74
EPS (Diluted)	-0.58	-6.74	-1.33	-2.07	1.70
EPS Growth	-	-	-	-	-44.56%
Free Cash Flow	-17.49	-16.47	-33.21	-16.84	-15.3
Free Cash Flow Per Share	-0.37	-0.43	-2.09	-2.22	-3.55
Gross Margin	56.73%	64.37%	-	100.00%	-
Operating Margin	-206.80%	-3311.46%	-	-9911.59%	-
Profit Margin	-201.18%	-2600.26%	-	-7589.37%	-
Free Cash Flow Margin	-129.18%	-167.87%	-	-8136.23%	-
EBITDA	-27.3	-324.89	-26.96	-19.62	-19.73
EBITDA Margin	-201.63%	-	-	-	-
D&A For EBITDA	0.7	0	0.95	0.9	0
EBIT	-28	-324.89	-27.91	-20.52	-19.73
EBIT Margin	-206.80%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.